Characterization of a germline mosaicism in families with Lowe syndrome, and identification of seven novel mutations in the OCRL1 gene
- PMID: 10364518
- PMCID: PMC1378076
- DOI: 10.1086/302443
Characterization of a germline mosaicism in families with Lowe syndrome, and identification of seven novel mutations in the OCRL1 gene
Abstract
The oculocerebrorenal syndrome of Lowe (OCRL) is an X-linked disorder characterized by major abnormalities of eyes, nervous system, and kidneys. Mutations in the OCRL1 gene have been associated with the disease. OCRL1 encodes a phosphatidylinositol 4, 5-biphosphate (PtdIns[4,5]P2) 5-phosphatase. We have examined the OCRL1 gene in eight unrelated patients with OCRL and have found seven new mutations and one recurrent in-frame deletion. Among the new mutations, two nonsense mutations (R317X and E558X) and three other frameshift mutations caused premature termination of the protein. A missense mutation, R483G, was located in the highly conserved PtdIns(4,5)P2 5-phosphatase domain. Finally, one frameshift mutation, 2799delC, modifies the C-terminal part of OCRL1, with an extension of six amino acids. Altogether, 70% of missense mutations are located in exon 15, and 52% of all mutations cluster in exons 11-15. We also identified two new microsatellite markers for the OCRL1 locus, and we detected a germline mosaicism in one family. This observation has direct implications for genetic counseling of Lowe syndrome families.
Similar articles
-
Spectrum of mutations in the OCRL1 gene in the Lowe oculocerebrorenal syndrome.Am J Hum Genet. 1997 Jun;60(6):1384-8. doi: 10.1086/515471. Am J Hum Genet. 1997. PMID: 9199559 Free PMC article.
-
Carrier assessment in families with lowe oculocerebrorenal syndrome: novel mutations in the OCRL1 gene and correlation of direct DNA diagnosis with ocular examination.Mol Genet Metab. 2000 Mar;69(3):213-22. doi: 10.1006/mgme.1999.2955. Mol Genet Metab. 2000. PMID: 10767176
-
Mutations are not uniformly distributed throughout the OCRL1 gene in Lowe syndrome patients.Mol Genet Metab. 1998 May;64(1):58-61. doi: 10.1006/mgme.1998.2687. Mol Genet Metab. 1998. PMID: 9682219
-
Crystal structure of the Rab binding domain of OCRL1 in complex with Rab8 and functional implications of the OCRL1/Rab8 module for Lowe syndrome.Small GTPases. 2012 Apr-Jun;3(2):107-10. doi: 10.4161/sgtp.19380. Small GTPases. 2012. PMID: 22790198 Review.
-
The cellular and physiological functions of the Lowe syndrome protein OCRL1.Traffic. 2014 May;15(5):471-87. doi: 10.1111/tra.12160. Epub 2014 Mar 7. Traffic. 2014. PMID: 24499450 Free PMC article. Review.
Cited by
-
Delayed vitreous haemorrhage after paediatric cataract surgery in Lowe syndrome.Eye (Lond). 2016 Sep;30(9):1272-3. doi: 10.1038/eye.2016.100. Epub 2016 May 27. Eye (Lond). 2016. PMID: 27229703 Free PMC article. No abstract available.
-
Maternal de novo triple mosaicism for two single OCRL nucleotide substitutions (c.1736A>T, c.1736A>G) in a Lowe syndrome family.Hum Genet. 2011 May;129(5):513-9. doi: 10.1007/s00439-010-0944-y. Epub 2011 Jan 12. Hum Genet. 2011. PMID: 21225285
-
Mutations in OCRL1 gene in Indian children with Lowe syndrome.Clin Exp Nephrol. 2008 Oct;12(5):358-362. doi: 10.1007/s10157-008-0059-0. Epub 2008 May 24. Clin Exp Nephrol. 2008. PMID: 18500547
-
Inherited cerebrorenal syndromes.Nat Rev Nephrol. 2009 Sep;5(9):529-38. doi: 10.1038/nrneph.2009.124. Nat Rev Nephrol. 2009. PMID: 19701229 Review.
-
Antenatal diagnosis of Lowe syndrome.Clin Exp Nephrol. 2010 Jun;14(3):296-7. doi: 10.1007/s10157-010-0267-2. Epub 2010 Feb 17. Clin Exp Nephrol. 2010. PMID: 20162319 No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources